ABK Biomedical Incorporated is a new medical device company co-founded by Materials Scientists, Dr. Daniel Boyd and Dr. Sharon Kehoe and an Interventional Radiologist, Dr. Bob Abraham. The company is driven by the unmet need to develop integrated devices to simplify clinical procedures performed by interventional radiologists. Initially, the company is particularly interested in uterine fibroid embolization (UFE). The founders have developed a novel radiopaque embolic agent that will allow UFE to be performed more efficiently and in a safer manner. ABK Biomedical will focus on bringing this technology to market while fostering development of additional technologies that will be added to ABK’s product pipeline.
ABK Biomedical Inc.
Innovacorp Enterprise Centre
1344 Summer St
ABK Biomedical inc. Contact Phone Number: 902-483-6689
Dr. Daniel Boyd
Co-Founder and Chief Scientific Officer
Dr. Bob Abraham
Co-Founder and Chief Medical Officer
Dr. Sharon Kehoe
Co-Founder and Technical Officer
See full and original Entrevestor article here Halifax medical device maker ABK Biomedical Inc. has raised a record-setting US$30 million venture capital round, with which it hopes to bring two products to market. The Series B round is equal to C$40 million, which is...
See original article in LINK Magazine Every year brilliant discoveries are made in Dalhousie University’s research labs but without commercialization support many of those discoveries may never lead to potential social or economic benefits. The Industry Liaison and...